Myocardium of patients with dilated cardiomyopathy presents altered expression of genes involved in thyroid hormone biosynthesis
Open Access
- 10 January 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (1) , e0190987
Abstract
The association between dilated cardiomyopathy (DCM) and low thyroid hormone (TH) levels has been previously described. In these patients abnormal thyroid function is significantly related to impaired left ventricular (LV) function and increased risk of death. Although TH was originally thought to be produced exclusively by the thyroid gland, we recently reported TH biosynthesis in the human ischemic heart. Based on these findings, we evaluated whether the genes required for TH production are also altered in patients with DCM. Twenty-three LV tissue samples were obtained from patients with DCM (n = 13) undergoing heart transplantation and control donors (n = 10), and used for RNA sequencing analysis. The number of LV DCM samples was increased to 23 to determine total T4 and T3 tissue levels by ELISA. We found that all components of TH biosynthesis are expressed in human dilated heart tissue. Expression of genes encoding thyroperoxidase (–2.57-fold, P < 0.05) and dual oxidase 2 (2.64-fold, P < 0.01), the main enzymatic system of TH production, was significantly altered in patients with DCM and significantly associated with LV remodeling parameters. Thyroxine (T4) cardiac tissue levels were significantly increased (P < 0.01), whilst triiodothyronine (T3) levels were significantly diminished (P < 0.05) in the patients. Expression of TH biosynthesis machinery in the heart and total tissue levels of T4 and T3, are altered in patients with DCM. Given the relevance of TH in cardiac pathology, our results provide a basis for new gene-based therapeutic strategies for treating DCM.Keywords
Funding Information
- National Institute of Health “Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III” Madrid, Spain (PI13/00100)
- National Institute of Health “Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III” Madrid, Spain (PI14/01506)
- Center for Biomedical Research Network in Cardiovascular Diseases (CIBERCV), Madrid, Spain (CB16/11/00261)
- European Regional Development Fund (FEDER), and Thematic Networks for Co-Operative Research in Health (RETICS), Madrid, Spain (12/0042/0003)
This publication has 42 references indexed in Scilit:
- Thyroid and the HeartThe American Journal of Medicine, 2014
- The Prevalence and Prognostic Effects of Subclinical Thyroid Dysfunction in Dilated Cardiomyopathy Patients: A Single-Center Cohort StudyJournal of Cardiac Failure, 2014
- Thyroid hormone and cardiovascular system: from basic concepts to clinical applicationInternal and Emergency Medicine, 2013
- Reverse T3 as a parameter of myocardial function impairment in heart failureInternational Journal of Cardiology, 2010
- Thyroid hormone improves postischaemic recovery of function while limiting apoptosis: a new therapeutic approach to support hemodynamics in the setting of ischaemia-reperfusion?Basic Research in Cardiology, 2009
- Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in ratsBasic Research in Cardiology, 2008
- Urinary B-Type Natriuretic Peptide Levels in the Diagnosis and Prognosis of Heart FailureJournal of Cardiac Failure, 2007
- Does subclinical hypothyroidism affect cardiac pump performance?JACC, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Influence of hypothyroidism and the reversal of hypothyroidism on hemodynamics and cell size in the adult rat heartJournal of Molecular and Cellular Cardiology, 1990